← 홈

ADC

505개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 505개
ADCBiologicstaleZhengda Tianqing Pharmaceutical…Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48+AK105+cisplatin)

Advanced Gastric Carcinoma; HER2-positive Gastric Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstaleSun Yat-sen UniversityPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48+Furmonertinib, 1L)

Non Small Cell Lung Cancer; ERBB2 Mutation-Related Tumors · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleSun Yat-sen UniversityPhase 2

disitamab vedotin (Disitamab Vedotin, RC48, RC48+Furmonertinib, 2L+)

Non Small Cell Lung Cancer; ERBB2 Mutation-Related Tumors · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 ACTIVE
ADCBiologicstaleCancer Institute and Hospital, …Preclinical

Radiotherapy + Novel Anti-tumor Drug (Radiotherapy + Novel Anti-tumor Drug)

Advanced Breast Cancer Brain Metastasis · Advanced Breast Cancer Brain Metastasis

#AdvancedBreastCancerBrainMetasta#ADC#Preclinical#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleXijing HospitalPhase 2

RC48-ADC (Recombinant humanized anti-HER2 monoclonal antibody-MMAE coupling agent, Recombinant humanized anti-HER2 monoclonal antibody-MMAE coupling agent (RC48-ADC))

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Rilvegostomig + TDXd (Rilvegostomig + TDXd)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

SHR-4602 (SHR-4602)

Breast Neoplasm; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleUnion Hospital, Tongji Medical …Phase 2

SHR-A1811,tratuzumab,pyrotinib,Nab-Paclitaxel (SHR-A1811,tratuzumab,pyrotinib,Nab-Paclitaxel)

Breast Cancer · Breast Cancer

#BreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleChina Medical University, ChinaPhase 2

SHR-A1904 (SHR-A1904)

Gastric Cancer; HER2 + Gastric Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
ADCBiologicstaleSOTIO Biotech a.s.Phase 2

SOT102 (SOT102)

Pancreatic Cancer · Pancreatic Cancer

#PancreaticCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 DISCONTINUED
ADCBiologicstaleSorrento Therapeutics, Inc.Phase 1

STI-3258 (STI-3258)

Relapsed Solid Neoplasm; Refractory Cancer · FRα

#FR#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 DISCONTINUED
ADCBiologicstaleSutro Biopharma, Inc.Phase 1

STRO-004 (STRO-004)

Head and Neck Squamous Cell Carcinoma HNSCC; Non-Small Cell Lung Cancer NSCLC · Head and Neck Squamous Cell Carcinoma HN

#HeadandNeckSquamousCellCarcinoma#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYH2051 tablets (SYH2051 tablets)

Advanced Solid Tumors; Breast Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

SYS6010 jnjection (SYS6010 jnjection)

Advanced Solid Tumors; Breast Cancer · Advanced Solid Tumors

#AdvancedSolidTumors#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleGileadPhase 2

sacituzumab govitecan (Trodelvy, Sacituzumab Govitecan、Datopotamab deruxtecan、Sacituzumab tirumotecan)

Metastatic Breast Cancer ( HER2 Negative) · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleFudan UniversityPhase 2

Observational Cohort (Sacituzumab Tirumotecan, Sacituzumab Tirumotecan (Observational Cohort))

Bladder Cancer; Metastatic Urothelial Carcinoma · Bladder Cancer

#BladderCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleThe First Affiliated Hospital o…Phase 2

sacituzumab govitecan (Trodelvy, Sacituzumab Tirumotecan Combined with Bevacizumab)

Platinum-resistant Recurrent Ovarian Cancer (PROC) · Platinum-resistant Recurrent Ovarian Can

#Platinum-resistantRecurrentOvari#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleRemeGen Co., Ltd.Phase 2

disitamab vedotin (Disitamab Vedotin, RC48, Short range radiotherapy with sequential Disitamab Vedotin combined with S-1 and xindilizumab)

Gastric Cancer · Gastric Cancer

#GastricCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleDaiichi Sankyo Co., Ltd.Phase 1

Steroid Containing Mouthwash (Steroid Containing Mouthwash)

Hormone Receptor Positive Breast Cancer; Triple Negative Breast Cancer · Hormone Receptor Positive Breast Cancer

#HormoneReceptorPositiveBreastCan#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
ADCBiologicstaleCancer Institute and Hospital, …Phase 2

TAEST1901 (TAEST1901)

Rare Malignant Neoplasm; Advanced Solid Tumors · Rare Malignant Neoplasm

#RareMalignantNeoplasm#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING

24 / 26 페이지

← 이전다음 →